C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/14/2002	US20020168364 Methods and compositions for modulating tumor growth
11/14/2002	US20020168363 Integrin/adhesion antagonists
11/14/2002	US20020168361 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit
11/14/2002	US20020168359 Human tumor necrosis factor receptor TR9
11/14/2002	US20020168356 An antibody capable of binding a PF4AR (platelet factor 4 superfamily member) polypeptide and the polypeptide is an interleukin-8 receptor; antiinflammatory agent
11/14/2002	US20020168349 A viral DNA construct encoding for a virus capable of replication in a human or animal tumor cell and causing death of such tumor cells
11/14/2002	US20020168348 Prolonging the acceptance of a graft by administering a short course of an immunosuppressant
11/14/2002	US20020168342 Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods
11/14/2002	US20020168338 Compositions and methods for delivery of agents for neuronal regeneration and survival
11/14/2002	US20020168323 Optimization of the molecular properties and formulation of proteins delivered by inhalation
11/14/2002	DE10121710A1 Assessing hormonal effects of compounds, useful in testing drugs, from effect on interaction of nuclear receptor and co-modulator, also diagnosing diseases caused by improper co-modulation
11/14/2002	DE10120265A1 AAV-Helferplasmide zur Helfervirus-freien Verpackung und Pseudotypisierung von AAV-Vektoren AAV helper plasmids for helper virus-free packaging and Pseudotyping AAV vectors
11/14/2002	CA2458207A1 Determination of a genetic predisposition for behavioural disorders
11/14/2002	CA2452844A1 Dose response-based methods for identifying receptors having alterations in signaling
11/14/2002	CA2452245A1 Recombinant fusion proteins and the trimers thereof
11/14/2002	CA2447386A1 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/14/2002	CA2446857A1 Reproductive cancer diagnosis and therapy
11/14/2002	CA2446838A1 Novel mutation
11/14/2002	CA2446819A1 Dna molecules encoding macaca mulatta androgen receptor
11/14/2002	CA2446788A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	CA2446735A1 Substituted cyclohexane-1,4-diamine derivatives with an anti-diarrhoea and peripheral analgesic action
11/14/2002	CA2446666A1 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002	CA2446640A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same
11/14/2002	CA2446458A1 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	CA2446437A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	CA2446427A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/14/2002	CA2446394A1 Insulinotropic peptide derivatives
11/14/2002	CA2446294A1 Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them
11/14/2002	CA2446274A1 Novel regulatory protein
11/14/2002	CA2446204A1 Anti-virus agent
11/14/2002	CA2446062A1 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
11/14/2002	CA2446031A1 Process for synthesizing protein using cell-free protein synthesis system
11/14/2002	CA2446022A1 Freeze-tolerant eukaryotic cells
11/14/2002	CA2445989A1 Colon cancer antigen panel
11/14/2002	CA2445982A1 Sperm-specific cation channel, and uses therefor
11/14/2002	CA2445933A1 Gelatin substitute
11/14/2002	CA2445682A1 Mutation induced optimization of receptor signal to noise ratio
11/14/2002	CA2445049A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002	CA2441417A1 Human secreted proteins
11/13/2002	EP1256804A1 HBcAg expression and diagnostic and therapeutic uses
11/13/2002	EP1256628A2 Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
11/13/2002	EP1256625A1 Immortalized vascular adventitial cell line
11/13/2002	EP1256354A1 Methods for treating cancer
11/13/2002	EP1256352A2 Immunomodulatory peptides
11/13/2002	EP1255993A2 Methods for identifying modulators for balance related disorders
11/13/2002	EP1255864A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255859A2 Tissue specific genes of diagnostic import
11/13/2002	EP1255857A2 Method of identifying toxic agents using differential gene expression
11/13/2002	EP1255853A2 Methods of protein destabilization and uses thereof
11/13/2002	EP1255852A1 Immunoassay and diagnostic reagent for malaria
11/13/2002	EP1255849A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
11/13/2002	EP1255847A2 Alteration of growth and adaptation under hypoxic conditions
11/13/2002	EP1255845A2 Modified cytokines for use in cancer therapy
11/13/2002	EP1255844A1 Humanized anti-ccr2 antibodies and methods of use therefor
11/13/2002	EP1255842A1 Larynx carcinoma-associated protein larcap-1
11/13/2002	EP1255841A2 Use of palatinase and trehalulase sequences as nutritive markers in transformed cells
11/13/2002	EP1255839A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
11/13/2002	EP1255838A1 Dehiscence gene and methods for regulating dehiscence
11/13/2002	EP1255837A2 Il-17 like molecules and uses thereof
11/13/2002	EP1255836A2 Novel, central nervous protein, that modulates k?+ flows
11/13/2002	EP1255835A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255834A2 Gtpase activating proteins
11/13/2002	EP1255833A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255832A1 18057 protein, a seven transmembrane protein
11/13/2002	EP1255831A2 Sperm specific proteins
11/13/2002	EP1255830A2 Cbp86, a sperm specific protein
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255826A2 Protein design automation for protein libraries
11/13/2002	EP1255825A2 Male tissue-specific regulatory region and method of using same
11/13/2002	EP1255817A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255815A1 Porcine reproductive and respiratory syndrome virus and methods of use
11/13/2002	EP1255814A1 7tm receptor axor36
11/13/2002	EP1255778A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255777A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255776A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255775A2 Process for the preparation of a mucosal form of the eosinophil cationic protein (ecp), mucosal ecp and uses thereof as allergic phlogosis marker
11/13/2002	EP1255774A1 Transgenic animal model for obesity expressing foxc2
11/13/2002	EP1255773A2 Insecticidal proteins from bacillus thuringiensis
11/13/2002	EP1255772A2 Biosensor compositions and methods of use
11/13/2002	EP1255771A1 Novel compounds
11/13/2002	EP1255770A1 Melanin-concentrating hormone analogs
11/13/2002	EP1255768A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255767A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255766A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255568A2 Conjugates targeted to target receptors
11/13/2002	EP1255562A2 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens
11/13/2002	EP1255558A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules
11/13/2002	EP1255554A2 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250
11/13/2002	EP1255447A2 Biopolymer thickener
11/13/2002	EP1255437A1 Transgenic animal expressing a multiple mutated form of presenilin 1
11/13/2002	EP1113811B1 Chemokine receptor antagonist and cyclosporin in combined therapy
11/13/2002	EP1084146B1 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
11/13/2002	EP1060261A4 Poly zinc finger proteins with improved linkers
11/13/2002	EP1012162B1 Soluble proteins
11/13/2002	EP0891378B1 Use of a pharmaceutical composition comprising an appetite-suppressing peptide
11/13/2002	EP0843557B1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
11/13/2002	EP0836482B1 Subunit vaccine against flavivirus infection
11/13/2002	EP0738281B1 Peptides and their uses against psoriasis
11/13/2002	EP0693940B1 Hybrid genes for use in the production of t h?-independent cytotoxic t cells
11/13/2002	EP0671926B1 Immunomodulatory peptides

1 ... 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 ... 2916